Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening.
about
HPV-Testing in Follow-up of Patients Treated for CIN2+ LesionsCurrent Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers.Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer.Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China.The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening.Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening.Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016.Role of high-risk human papillomavirus in the etiology of oral and oropharyngeal cancers in Thailand: A case-control study.Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
P2860
Q26771420-25928C5F-F6D1-4001-9A39-43675028DE60Q28072364-C4D9F255-2294-4AC4-8351-232089A70639Q35807133-6FD02160-8BB4-4B61-86E4-667A73E9A110Q35816897-90AA6869-F713-4D8F-8137-FF3FBF5A4F16Q37218627-D955B918-9A9F-4A7F-9383-9D9E1F623964Q40043990-8B7C13EC-F587-4FE2-989D-021905147778Q54263622-A4166DF1-30FD-4C55-9FEF-925260FCD07AQ55016932-EBC9C9C9-CE84-4B1A-9C21-988FBC98FBC4Q58764889-5AB24652-3514-450C-88FF-36D06DFB97D5
P2860
Clinical validation of the Cervista HPV HR test according to the international guidelines for human papillomavirus test requirements for cervical cancer screening.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical validation of the Cer ...... for cervical cancer screening.
@ast
Clinical validation of the Cer ...... for cervical cancer screening.
@en
type
label
Clinical validation of the Cer ...... for cervical cancer screening.
@ast
Clinical validation of the Cer ...... for cervical cancer screening.
@en
prefLabel
Clinical validation of the Cer ...... for cervical cancer screening.
@ast
Clinical validation of the Cer ...... for cervical cancer screening.
@en
P2093
P2860
P356
P1476
Clinical validation of the Cer ...... for cervical cancer screening.
@en
P2093
Aniek Boers
Ate G J van der Zee
Bettien M van Hemel
Ed Schuuring
G Bea A Wisman
Hilde Ghyssaert
Lorian Slagter-Menkema
P2860
P304
P356
10.1128/JCM.02716-14
P407
P577
2014-10-08T00:00:00Z